Diseases, Conditions, Syndromes

Only half newly reported HCV cases receiving follow-up test

(HealthDay)—The lack of a hepatitis C virus (HCV) RNA test for approximately one-half of persons newly reported as HCV infected suggests that testing and reporting must improve to detect all persons with current infection, ...

Diseases, Conditions, Syndromes

Non-specialists can expand hepatitis C treatment access

(HealthDay)—Non-specialists, including primary care providers (PCPs) and nurse practitioners (NPs), safely and effectively administer direct-acting antiviral therapy for hepatitis C virus (HCV) to patients seen in federally ...

Diseases, Conditions, Syndromes

Hepatitis C on the rise among reproductive-aged women

The number of hepatitis C virus (HCV) cases reported in reproductive-aged women in the United States has increased substantially in recent years. Thus, more children are being born to HCV-infected mothers than at any time ...

Diseases, Conditions, Syndromes

Total medical costs of $16K for IFN-based antiviral tx for HCV

(HealthDay)—The total medical costs associated with interferon (IFN)-based antiviral treatment among patients with chronic hepatitis C virus (HCV) infection average €14,559, with a mean cost of €38,514 per sustained ...

page 10 from 15